Despite no specific mention of liver disease, this is a huge part of the Horizon 2020 agenda so research projects linking liver disease to diabetes or retinal disease should be considered. Read more....
The position involves a strong focus on improving the estimation of burden of disease. Read more...
Read the global policy and civil society report on prevention and control of viral hepatitis
Now 4059 members from 106 countries
Clinical Practice Guidelines

Clinical Practice Guidelines (CPG) define the use of diagnostic, therapeutic and preventive modalities, including non-invasive and invasive procedures, in the management of patients with various liver diseases. They are intended to assist physicians and other healthcare providers, as well as, patients and interested individuals in the clinical decision making process by describing a range of generally accepted approaches for the diagnosis, treatment and prevention of specific liver diseases. CPGs have to be distinguished from consensus statements and position papers.

  • A consensus statement reports the conclusions of a consensus conference
  • A position paper reflects the opinions of experts

EASL Recommendations on Treatment of Hepatitis C
EASL Recommendations on Treatment of Hepatitis C
read, view or download

EASL HCV recommendations, 2014

by Prof. J.M. Pawlotsky at the International Liver Congress™ 2014, London

NEW Translated CPG's Now Available

translated-clinical-practice-guides

Future Guidelines (work in progress):

  • Liver Transplant
  • Management of Acute Liver Failure
  • Vascular Liver Disease
  • Gallstones
  • Liver biochemistry tests in the diagnosis and management of liver disease

Other Recommendations

Share
New releases

Practice Guidelines by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases.

EASL is pleased to announce the publication of its 9th Clinical Practice Guidelines (CPG) on the Management of Alcoholic Liver Disease.

April 2012, in the run-up to The International Liver Congress™ 2012, EASL releases revised CPGs on the Management of Chronic Hepatitis B originally released in October 2008... read more

EASL is pleased to announce the publication of its 7th Clinical Practice Guidelines (CPG) on the Management of Hepatocellular Carcinoma.

Developed to assist physicians and other healthcare providers in the diagnosis and management of patients with Wilson’s disease. The goal of these CPGs is to describe a number of generally accepted approaches for diagnosis, prevention, and treatment of Wilson’s disease.

EASL is pleased to announce the release of the revised EASL Clinical Practice Guidelines on the management of hepatitis C virus infection (HCV)

The 2013 guidelines, which supersede the previous version published in 2011, are designed to help physicians and other healthcare providers optimise their management of patients with acute and chronic HCV

EASL is pleased to announce the publication of its 4th Clinical Practice Guidelines on the Management of Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome in Cirrhosis.

EASL is pleased to announce the publication of its 3rd Clinical Practice Guidelines on the Management of HFE Hemochromatosis (HFE-HC).

Document to download

In October 2008, EASL proudly published its first CPG on the Management of Chronic Hepatitis B. Eight months later, new subject matter was published in the same series of Clinical Practice Guidelines; this time on the Management of Cholestatic Liver Diseases.

Document to download

Worldwide, hepatitis B virus is a major cause of liver disease (acute and chronic hepatitis, cirrhosis and liver cancer). Approximately, 350 million individuals are infected.

Document to download
Management of Chronic Hepatitis B 244.95 kb | pdf for PC